Clarifies Segment Reporting in Financial Results
Supriya Lifescience Limited · SUPRIYA · NSE ·
In response to a query from the National Stock Exchange (NSE) dated March 10, 2026, the company has provided a clarification regarding its financial results submitted on February 9, 2026. The company confirmed that it operates in a single business segment, namely Pharmaceuticals.…